CCCC icon

C4 Therapeutics

115 hedge funds and large institutions have $281M invested in C4 Therapeutics in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+9
Holders Change %
+8.49%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
35
Increased
32
Reduced
34
Closed
25
Calls
$3.53M
Puts
$1.18M
Net Calls
+$2.35M
Net Calls Change
+$71K
Name Holding Trade Value Shares
Change
Shares
Change %
GCM
126
Graham Capital Management
Connecticut
-$388K -47,449 Closed
Mirae Asset Global Investments
127
Mirae Asset Global Investments
South Korea
-$260K -41,445 Closed
DM
128
Deerfield Management
New York
-$234K -28,590 Closed
Walleye Trading
129
Walleye Trading
New York
-$203K -24,794 Closed
RA
130
Royce & Associates
New York
-$193K -23,604 Closed
SG Americas Securities
131
SG Americas Securities
New York
-$183K -22,368 Closed
PCMH
132
Polymer Capital Management (HK)
Hong Kong
-$179K -21,906 Closed
LP
133
LMR Partners
United Kingdom
-$160K -19,563 Closed
OQS
134
Occudo Quantitative Strategies
Florida
-$150K -18,317 Closed
ET
135
Entropy Technologies
New York
-$126K -15,391 Closed
Principal Financial Group
136
Principal Financial Group
Iowa
-$108K -13,238 Closed
QT
137
Quantbot Technologies
New York
-$84.2K -10,300 Closed
Macquarie Group
138
Macquarie Group
Australia
-$33 -4,009 Closed
US Bancorp
139
US Bancorp
Minnesota
-$319 -39 Closed